Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. [electronic resource]
Producer: 20101228Description: 935-45 p. digitalISSN:- 1179-2027
- Adalimumab
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Comparative Effectiveness Research -- methods
- Etanercept
- Humans
- Immunoglobulin G -- therapeutic use
- Psoriasis -- drug therapy
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.